1
|
Velez CO, Javierre GV, Zamora E, Alvarez AG, Illescas D, Viaplana C, Batista M, Martinez M, Garcia-Patos V, Bodet-Castillo D, Fabregas BF, Recio J, Losa JH, Alberú XV, Dienstmann R, Muñoz-Couselo E. 438P Real-world data of relapse after adjuvant treatment (Tx) in high-risk melanoma. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.10.430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
2
|
Ros Montañá F, Baraibar Argota I, Ortiz Velez C, Grau Béjar J, Villacampa G, Garcia-Patos V, Bodet D, Fernandez-Pulido C, Dienstmann R, Muñoz-Couselo E. Clinical and laboratory markers as predictors of time to treatment failure (TTF) and overall survival (OS) in patients (pts) with mucosal melanoma (MM). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy439.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
3
|
Hernando A, Dienstmann R, Ortiz Velez C, Villacampa G, Ros Montañá F, Grau Béjar J, Garcia-Alvarez A, Nuciforo P, Gros A, Garcia-Patos V, Bodet D, Ferrer Fabrega B, Recio J, Muñoz-Couselo E. Dynamics of clinical biomarkers as predictors of immunotherapy (IT) benefit in metastatic melanoma (MM) patients (pts) treated in reference institution. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy439.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
4
|
Pérez-Alea M, McGrail K, Sánchez-Redondo S, Ferrer B, Fournet G, Cortés J, Muñoz E, Hernandez-Losa J, Tenbaum S, Martin G, Costello R, Ceylan I, Garcia-Patos V, Recio JA. ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment. Oncogene 2017; 36:5695-5708. [PMID: 28581514 DOI: 10.1038/onc.2017.160] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2016] [Revised: 04/18/2017] [Accepted: 04/18/2017] [Indexed: 12/12/2022]
Abstract
Despite the promising targeted and immune-based interventions in melanoma treatment, long-lasting responses are limited. Melanoma cells present an aberrant redox state that leads to the production of toxic aldehydes that must be converted into less reactive molecules. Targeting the detoxification machinery constitutes a novel therapeutic avenue for melanoma. Here, using 56 cell lines representing nine different tumor types, we demonstrate that melanoma cells exhibit a strong correlation between reactive oxygen species amounts and aldehyde dehydrogenase 1 (ALDH1) activity. We found that ALDH1A3 is upregulated by epigenetic mechanisms in melanoma cells compared with normal melanocytes. Furthermore, it is highly expressed in a large percentage of human nevi and melanomas during melanocyte transformation, which is consistent with the data from the TCGA, CCLE and protein atlas databases. Melanoma treatment with the novel irreversible isoform-specific ALDH1 inhibitor [4-dimethylamino-4-methyl-pent-2-ynthioic acid-S methylester] di-methyl-ampal-thio-ester (DIMATE) or depletion of ALDH1A1 and/or ALDH1A3, promoted the accumulation of apoptogenic aldehydes leading to apoptosis and tumor growth inhibition in immunocompetent, immunosuppressed and patient-derived xenograft mouse models. Interestingly, DIMATE also targeted the slow cycling label-retaining tumor cell population containing the tumorigenic and chemoresistant cells. Our findings suggest that aldehyde detoxification is relevant metabolic mechanism in melanoma cells, which can be used as a novel approach for melanoma treatment.
Collapse
Affiliation(s)
- M Pérez-Alea
- Biomedical Research in Melanoma-Animal Models and Cancer Laboratory-Oncology Program, Vall d'Hebron Research institute VHIR-Vall d'Hebron Hospital, Barcelona-UAB, Spain
| | - K McGrail
- Biomedical Research in Melanoma-Animal Models and Cancer Laboratory-Oncology Program, Vall d'Hebron Research institute VHIR-Vall d'Hebron Hospital, Barcelona-UAB, Spain
| | - S Sánchez-Redondo
- Biomedical Research in Melanoma-Animal Models and Cancer Laboratory-Oncology Program, Vall d'Hebron Research institute VHIR-Vall d'Hebron Hospital, Barcelona-UAB, Spain
| | - B Ferrer
- Biomedical Research in Melanoma-Animal Models and Cancer Laboratory-Oncology Program, Vall d'Hebron Research institute VHIR-Vall d'Hebron Hospital, Barcelona-UAB, Spain.,Anatomy Pathology Department, Vall d'Hebron Hospital, Barcelona-UAB, Spain
| | - G Fournet
- Institut de Chimie et Biochimie Moléculaire et Supramoléculaire, UMR-CNRS 5246, Université de Lyon, Université Claude Bernard-Lyon1, Villeurbanne, France
| | - J Cortés
- Ramon y Cajal University Hospital, Madrid, Spain.,Clinical Oncology Program, Vall d'Hebron Institute of Oncology-VHIO, Vall d'Hebron Hospital, Barcelona-UAB, Spain
| | - E Muñoz
- Clinical Oncology Program, Vall d'Hebron Institute of Oncology-VHIO, Vall d'Hebron Hospital, Barcelona-UAB, Spain
| | - J Hernandez-Losa
- Anatomy Pathology Department, Vall d'Hebron Hospital, Barcelona-UAB, Spain
| | - S Tenbaum
- Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain
| | - G Martin
- Advanced BioDesign, Parc Technologique de Lyon, Woodstock - Bâtiment Cèdre 1, Saint Priest, France
| | - R Costello
- Service d'Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire La Conception, Marseille, France
| | - I Ceylan
- Advanced BioDesign, Parc Technologique de Lyon, Woodstock - Bâtiment Cèdre 1, Saint Priest, France
| | - V Garcia-Patos
- Biomedical Research in Melanoma-Animal Models and Cancer Laboratory-Oncology Program, Vall d'Hebron Research institute VHIR-Vall d'Hebron Hospital, Barcelona-UAB, Spain.,Dermatology Department, Vall d'Hebron Hospital, Barcelona-UAB, Spain
| | - J A Recio
- Biomedical Research in Melanoma-Animal Models and Cancer Laboratory-Oncology Program, Vall d'Hebron Research institute VHIR-Vall d'Hebron Hospital, Barcelona-UAB, Spain
| |
Collapse
|
5
|
Martin-Ezquerra G, Masferrer E, Masferrer-Niubò M, Ferran M, Sánchez-Regaña M, Collgros H, Bordas X, Notario J, Alsina M, Gil I, Izquierdo N, Aparicio G, Mollet J, Garcia-Patos V, Pujol R. Use of biological treatments in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2014; 29:56-60. [DOI: 10.1111/jdv.12438] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2013] [Accepted: 01/31/2014] [Indexed: 01/28/2023]
Affiliation(s)
| | - E. Masferrer
- Dermatology Department; Hospital del Mar; Barcelona Spain
| | - M. Masferrer-Niubò
- Mathematic Department; Universidad Nacional de Educación a Distancia UNED; Barcelona Spain
| | - M. Ferran
- Dermatology Department; Hospital del Mar; Barcelona Spain
| | | | - H. Collgros
- Dermatology Department; Hospital Sagrat Cor; Barcelona Spain
| | - X. Bordas
- Dermatology Department; Hospital de Bellvitge; Barcelona Spain
| | - J. Notario
- Dermatology Department; Hospital de Bellvitge; Barcelona Spain
| | - M. Alsina
- Dermatology Department; Hospital Clínic; Barcelona Spain
| | - I. Gil
- Dermatology Department; Hospital Sant Joan de Reus; Reus Spain
| | - N. Izquierdo
- Dermatology Department; Hospital Son Espases; Palma de Mallorca Spain
| | - G. Aparicio
- Dermatology Department; Hospital de la Vall d ‘Hebron; Barcelona Spain
| | - J. Mollet
- Dermatology Department; Hospital de la Vall d ‘Hebron; Barcelona Spain
| | - V. Garcia-Patos
- Dermatology Department; Hospital de la Vall d ‘Hebron; Barcelona Spain
| | - R.M. Pujol
- Dermatology Department; Hospital del Mar; Barcelona Spain
| |
Collapse
|
6
|
Kennedy F, Hilari H, Ferrer B, Garcia-Patos V. Lichenoid Chronic Graft-vs-Host Disease Following Blaschko Lines. Actas Dermo-Sifiliográficas (English Edition) 2014. [DOI: 10.1016/j.adengl.2012.12.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
7
|
Kennedy FE, Hilari H, Ferrer B, Garcia-Patos V. Lichenoid chronic graft-vs-host disease following Blaschko lines. Actas Dermosifiliogr 2013; 105:89-92. [PMID: 23668622 DOI: 10.1016/j.ad.2012.12.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2012] [Revised: 12/10/2012] [Accepted: 12/27/2012] [Indexed: 10/26/2022] Open
Affiliation(s)
- F E Kennedy
- Servicio de Dermatología, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España.
| | - H Hilari
- Servicio de Dermatología, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España
| | - B Ferrer
- Servicio de Anatomía Patológica, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España
| | - V Garcia-Patos
- Servicio de Dermatología, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España
| |
Collapse
|
8
|
Perez-Garcia J, Morales R, Valverde CM, Rodon J, Suarez C, Semidey ME, Garcia-Patos V, Bartralot R, Serra M, Carles J. Eccrine porocarcinoma presenting with scrotal lymphedema: a case report and review of systemic treatment. Ann Oncol 2010; 21:907. [PMID: 20089564 DOI: 10.1093/annonc/mdp601] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | | | | | - J Rodon
- Department of Medical Oncology
| | | | | | - V Garcia-Patos
- Department of Dermatology, Vall d'Hebron University Hospital, Barcelona, Spain
| | - R Bartralot
- Department of Dermatology, Vall d'Hebron University Hospital, Barcelona, Spain
| | - M Serra
- Department of Dermatology, Vall d'Hebron University Hospital, Barcelona, Spain
| | | |
Collapse
|
9
|
Ferrandiz-Pulido C, Bartralot R, Fuente MJ, Heras C, Bassas P, Aparicio G, Bodet D, Mollet J, Tortola MT, Garcia-Patos V. Postoperative pyoderma gangrenosum: diagnostic value of 16s ribosomal RNA sequencing and review of the literature. Clin Exp Dermatol 2009; 34:598-602. [DOI: 10.1111/j.1365-2230.2008.03049.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Bartralot R, Garcia-Patos V, Hueto J, Huguet P, Raspall G, Castells A. Angiolymphoid hyperplasia with eosinophilia affecting the oral mucosa: report of a case and a review of the literature. Br J Dermatol 1996; 134:744-8. [PMID: 8733384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Angiolymphoid hyperplasia with eosinophilia (ALHE) is an uncommon disorder of unknown aetiology. Clinically, it is characterized by cutaneous papules or nodules on the head and neck, and extracutaneous involvement is rare. We report a 30-year-old woman who had an asymptomatic submucosal nodule on the upper lip, which histopathologically showed features of ALHE, and review the previously described 15 cases of oral ALHE.
Collapse
Affiliation(s)
- R Bartralot
- Department of Dermatology, Hospital General Universitari Vall d'Hebron, Barcelona, Spain
| | | | | | | | | | | |
Collapse
|
11
|
|
12
|
Roger A, Guspi R, Garcia-Patos V, Barriga A, Rubira N, Nogueiras C, Castells A, Cadahia A. Occupational protein contact dermatitis in a veterinary surgeon. Contact Dermatitis 1995; 32:248-9. [PMID: 7600790 DOI: 10.1111/j.1600-0536.1995.tb00685.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Affiliation(s)
- A Roger
- Department of Allergy, Hospital Vall d'Hebron, Universitat Autónoma, Barcelona, Spain
| | | | | | | | | | | | | | | |
Collapse
|
13
|
|
14
|
Espinós JJ, Garcia-Patos V, Guiu XM, Delgado E. Early skin metastasis of endometrial adenocarcinoma: case report and review of the literature. Cutis 1993; 52:109-11. [PMID: 8404015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
A seventy-seven-year-old patient presented with skin metastasis from endometrial adenocarcinoma in a laparotomy scar, seven months after surgery. On reviewing current literature, it was clear that this was an unusual site for metastasis. We review the possible pathologic mechanism of this recurrence, its prognosis, and treatment.
Collapse
Affiliation(s)
- J J Espinós
- Department of Obstetrics and Gynecology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | | | | | | |
Collapse
|
15
|
Garcia-Patos V. Cytomegalovirus-induced cytopathic changes in skin biopsy specimens: clinicopathologic study in patients with the acquired immunodeficiency syndrome and an active extracutaneous cytomegalovirus infection. ACTA ACUST UNITED AC 1992. [DOI: 10.1001/archderm.128.11.1552] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|